Cantoni Therapeutics
PrivateLast Round
Seed
Sep 16, 2025
Company Overview
Cantoni Therapeutics is a biotechnology company developing small molecule inhibitors of nicotinamide N-methyltransferase (NNMT) for the treatment of obesity and its comorbidities.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Revenue Share, Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Cantoni Therapeutics Comps
Public and private peers based on sector, stage, and business model.
Cantoni Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Sep 16, 2025 | ||||
| Pre Seed | Dec 1, 2022 |
Cantoni Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Brabantse Ontwikkelings Maatschappij | Seed |
| Libertatis Ergo Holding | Pre Seed, Seed |
| Brabant Startup Fonds | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Sep 16, 2025
Led by Libertatis Ergo Holding with participation from Brabant Startup Fonds and Brabantse Ontwikkelings Maatschappij.
- Sep 19, 2024
Grew 75% QoQ, from 4 to 7 employees.
Cantoni Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Cantoni Therapeutics's valuation, stock price, and market status.
